GRAIL completes enrolment for Galleri MCED test trial
GRAIL has completed the planned enrolment of more than 35,000 subjects for the PATHFINDER 2 study, which is evaluating the…
GRAIL has completed the planned enrolment of more than 35,000 subjects for the PATHFINDER 2 study, which is evaluating the…
Researchers from the University of Cambridge’s Department of Psychology have developed a new AI model that outperforms current clinical tests…
Shifamed portfolio company Adona Medical has raised $33.5m in a Series C financing round for supporting the next stage of…
EnsoData has expanded its capabilities in sleep apnoea screening and diagnosis with the acquisition of diagnostic technology from Resonea. This…
SkylineDx has completed patient enrolment for the landmark MERLIN_001 study of the Merlin Assay, which is set to advance melanoma…
Mainz Biomed has submitted an application to the US Food and Drug Administration (FDA) seeking breakthrough device designation for its…
Pulse Biosciences has announced the receipt of breakthrough device designation from the US Food and Drug Administration (FDA) for its…
Researchers at the University of Birmingham in the UK are developing a saliva test that could identify children in the…
Hoya Group unit Pentax Medical America has received 510(k) clearance from the US Food and Drug Administration for its 4K video processor,…
ALPINION Medical Systems has introduced the new portable ultrasound diagnostic device, X-CUBE i9. The device features dual batteries and probe…